Focus Partners Advisor Solutions’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14K Buy
+11,026
New +$17.2K ﹤0.01% 1380
2026
Q1
– Sell
-12,216
Closed -$19.4K – 1272
2025
Q4
$19.4K Sell
12,216
-35
-0.3% -$73 ﹤0.01% 1084
2025
Q3
$28.5K Sell
12,251
-3,344
-21% -$6.31K ﹤0.01% 1124
2025
Q2
$19.6K Buy
15,595
+2,533
+19% +$2.49K ﹤0.01% 1092
2025
Q1
$11.9K Buy
13,062
+935
+8% +$1.22K ﹤0.01% 968
2024
Q4
$19.3K Buy
+12,127
New +$24.4K ﹤0.01% 769

Other funds holding CRBU

Focus Partners Advisor Solutions's CRBU Position: Q3 2026 in Review

Focus Partners Advisor Solutions opened a new position in Caribou Biosciences (CRBU) in Q3 2026: 11,026 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #1380 among its holdings. This is a return to the name: Focus Partners Advisor Solutions previously reported a position in CRBU as recently as Q4 2025.

Focus Partners Advisor Solutions first reported a position in CRBU in Q4 2024 and has held it in 6 quarters since. The position peaked at $28.5K in Q3 2025. 147 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

  • Focus Partners Advisor Solutions held 11,026 shares of Caribou Biosciences worth $14K as of Q3 2026.
  • Caribou Biosciences was a new Focus Partners Advisor Solutions position in Q3 2026.
  • Caribou Biosciences made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q3 2026, its #1380 holding.
  • Focus Partners Advisor Solutions first reported a position in Caribou Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Focus Partners Advisor Solutions's Caribou Biosciences position peaked at $28.5K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2026, filed 10 Nov 2026.